All In Biotech

Drug Trial Radar · NCT07866066

Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes

A Phase 3, Randomized, Open-Label Trial Comparing the Efficacy and Safety of Maridebart Cafraglutide Once Monthly Versus Semaglutide Once Weekly as Add-on Therapy to Metformin With or Without a Sodium-glucose Cotransporter-2 Inhibitor in Participants With Type 2 Diabetes

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,300 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,300

Planned (sponsor's estimate)

Start

Oct 16, 2026

Primary completion

Sep 6, 2028

Study completion Dec 5, 2028

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 8, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main objective of this trial is to evaluate whether maridebart cafraglutide is non-inferior to semaglutide in improving glycemic control in participants with type 2 diabetes (T2D) who are receiving metformin treatment, with or without a sodium-glucose cotransporter-2 (SGLT-2) inhibitor.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • Maridebart cafraglutideDrug

    Administered subcutaneously.

  • SemaglutideDrug

    Administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Hemoglobin A1c (HbA1c) at Week 68 [Non-inferiority]Time frame: Baseline to Week 68

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Acclaim Clinical Research

    San Diego, California · Recruiting

  • Bioclinical Research Alliance

    Miami, Florida · Recruiting

  • Indago Research and Health Center

    Miami Lakes, Florida · Recruiting

  • Clinical Research Center Of Florida

    Pompano Beach, Florida · Recruiting

  • Conquest Research - Winter Park

    Winter Park, Florida · Recruiting

  • Virginia Nephrology Group

    Arlington, Virginia · Recruiting

  • Eastside Research Associates Health Research

    Redmond, Washington · Recruiting

  • Dr T G Elliott Incorporated - BC Diabetes

    Vancouver, British Columbia, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.